Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.1968
+0.00331.71%
Volume:861.94K
Turnover:158.19K
Market Cap:26.68M
PE:-0.86
High:0.1982
Open:0.1915
Low:0.1748
Close:0.1935
52wk High:0.9400
52wk Low:0.1748
Shares:135.57M
Float Shares:92.35M
Volume Ratio:1.11
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2288
EPS(LYR):-0.3117
ROE:-730.06%
ROA:-148.34%
PB:-0.77
PE(LYR):-0.63

Loading ...

VolitionRX Issues Unregistered Shares to Lind Global Asset Management XII LLC

Reuters
·
Feb 21

VolitionRX Appoints MBL as Distributor for Nu.Q Discover Assays in Japan

Reuters
·
Feb 10

VolitionRx Faces NYSE American Non-Compliance Notice Over Equity Requirements

Reuters
·
Feb 10

VolitionRX Receives Notice of Non-Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Feb 10

VolitionRx Unveils Clinical Study Showing Nu.Q NETs Blood Test Guides Hidradenitis Suppurativa Treatment

Reuters
·
Feb 04

VolitionRX Limited Announces the Preparation of Reimbursement Submission for Its Nu.q® Cancer Assays

THOMSON REUTERS
·
Jan 30

VolitionRX Ltd: Once Reimbursement Achieved Anticipate Introduction of Nu.q Into Routine Clinical Use in France by Q4, 2026

THOMSON REUTERS
·
Jan 30

VolitionRx Unveils Study Supporting Nu.Q NETs Blood Test for Hidradenitis Suppurativa Management

Reuters
·
Jan 28

Volition Announces Data to Support Use of Nu.q® Nets in New Indication

THOMSON REUTERS
·
Jan 27

VolitionRX Ltd. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 27

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

VolitionRX Expands Nu.Q Vet Cancer Test Access With New Laboratory Providers

Reuters
·
Jan 20

VolitionRX Ltd. Showcases Nu.Q Vet Cancer Test at VMX Veterinary Conference

Reuters
·
Jan 16

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 09

BRIEF-Volitionrx Ltd Enters Amended Securities Purchase Agreement

Reuters
·
Jan 08

VolitionRX Ltd - Enters Amended Securities Purchase Agreement

THOMSON REUTERS
·
Jan 08

VolitionRX Ltd - to Receive $2,000,000 From Investor

THOMSON REUTERS
·
Jan 08

Press Release: VolitionRx Secures $2.0 Million in Funding

Dow Jones
·
Jan 08

VolitionRX Ltd. unveils corporate deck highlighting cancer and sepsis diagnostics, licensing strategy, and global commercialization plans

Reuters
·
Jan 08

VolitionRx Unveils Breakthrough Liquid Biopsy Test for Feline Cancer Detection

Reuters
·
Jan 08